GovChime
Notice ID: 60ebb389d7104772aff46833306bccd0Special NoticeArchived

Pinpoint Laser Systems laser alignment system

Archived on January 28, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
8:00 AM CST
Posted
January 9, 2026
Notice type
Special Notice
NAICS
334516: Analytical Laboratory Instrument Manufacturing
Agency
National Aeronautics and Space Administration

Notice details

Office
NASA SHARED SERVICES CENTER
Place of performance
Greenbelt, Maryland, 20771
Last updated
Nov 4, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
80NSSC26922479Q
Notice ID
60ebb389d7104772aff46833306bccd0

Description

**THIS IS A SOLE SOURCE REQUIREMENT** for Pinpoint Laser Systems laser alignment system

**AUTHORIZED RESELLERS ONLY**

**SEE ATTACHMENTS**

Full description on SAM.gov

Award Overview

Possible prior contract

Inferred, not confirmed

Inferred, not confirmed. Matched by agency, NAICS, place of performance and end-date proximity. This is a candidate, not the contractor of record.

Contract end date

Aug 1, 2025

NAICS

334516

Agency

National Aeronautics and Space Administration

Dollar amounts are not shown for inferred matches because the link is heuristic. Open the award below to check it.

Contacts

Contracting Officer

Primary Contact

Documents

Files (2)

  • SATPC0040193 TAB 04 4 SOW.pdf

    119 KBAdded in Special Notice version 3Posted
    Download
  • SATPC0040193 TAB 06 RDSS..pdf

    135 KBAdded in Special Notice version 3Posted
    Download

Lifecycle

  1. 3
    Version 3Special NoticeArchivedCurrent

    Pinpoint Laser Systems laser alignment system

    Notice 60ebb389d7104772aff46833306bccd0 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
NASA/NSSC has a requirement for Flight Model Solar Array Wings. See the attached SOW and request for capability statements for full details of the requirement. ALL CORRESPONDENCE MUST REFERENCE THE NOTICE ID IN THE SUBJECT LINE WHEN SUBMITTING A CAPABILITY STATEMENT. NOTE: Quotes received in response to this notice will NOT be considered and will not be evaluated by NASA’s Technical End User Team. We are currently only requesting Capability Statements.
-Special Notice10/28/2026
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Illumina, Inc. Acquisition Description: The purpose of this acquisition is to purchase two Illumina MiSeq i100 series instruments. These instruments will be used by the NIH HLA Laboratory to produce high resolution HLA typing results for the numerous transplant protocols supported by the laboratory. It will replace the current Illumina MiSeq instruments in the lab that were purchased in 2021 and 2022. The vendor will discontinue service on the current model of the MiSeq. New instruments are required to ensure time to validate these replacements before discontinuation of service. The total dollar value for this order is $139,100.52. The MiSeq is an integrated instrument that performs clonal amplification, genomic DNA sequencing, and data analysis with base calling, alignment, variant calling, and reporting in a single run. The MiSeq provides the Lab with the highest HLA typing results possible. The transplant protocols served by the HLA Lab require highest resolution possible to increase the chance of a successful transplant. The HLA Lab currently owns two MiSeq instruments, so the procedures and Quality Control assessments are in place. The order aims to replace the Illumina Miseq – s/n M07700 (property ID is 02223449) and s/n M08636 (property ID is 02268689) that were purchased in 2019 and 2022. Replacement is necessary to ensure proper performance of these instruments prior to discontinuation of service for the current model of the Illumina MiSeq instruments by the vendor. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000836) by 12:00 PM eastern standard time on 11/27/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
-Pre-Solicitation11/27/2026
Answers to Questions attached. Questions are due by 11:00 AM Monday, 16 November 2026. The proposal due date has not been extended.
-Solicitation11/23/2026
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith FAR Subpart 12.6, as supplemented with additional information included in thisnotice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00077. This solicitation is issued as a competitiveRequest for Quotation (RFQ) / combined synopsis/solicitation for commercial productsand commercial services using a Brand Name restriction in accordance with FAR 13.106-1(b)(1)(i). A Brand Name Justification is attached to this notice in accordance with FAR5.102(a)(6). This acquisition is conducted under the authority of FAR 12.603, StreamlinedSolicitation for Commercial Products or Commercial Services, in conjunction with FAR Part13 Simplified Acquisition Procedures, and is not expected to exceed the simplifiedacquisition threshold. The National Institutes of Health (NIH), Office of the Director, Officeof Acquisitions, seeks to award a Firm-Fixed-Price (FFP) Purchase Order to theresponsible offeror whose quotation represents the best value to the Government. (iii)The solicitation document and incorporated provisions and clauses are those in effectthrough Federal Acquisition Circular (FAC) number 2026-01 and effective date 03/13/2026. (iv)The associated NAICS code is 334516 (Analytical Laboratory InstrumentManufacturing), and the small business size standard is 1,000 employees. The ProductService Code (PSC) is 6640 (Laboratory Equipment and Supplies). [X]This requirement is set aside for Small Business concerns.
-Combined Synopsis11/24/2026
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00072. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services restricted to the Brand Name specified herein in accordance with FAR 13.106-1(b)(1)(i). The Government intends to award a firm-fixed-price purchase order resulting from this solicitation using competition among the Original Equipment Manufacturer (OEM) and its authorized distributors. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, on behalf of the National Heart, Lung, and Blood Institute (NHLBI), seeks to award a firm-fixed-price purchase order to the responsible offeror whose proposal represents the best value to the Government. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing), and the small business size standard is 1,000 employees. ¿ This requirement is unrestricted. (v) Description of Requirement: The National Heart, Lung, and Blood Institute (NHLBI), Laboratory of Advanced Microscopy and Biophotonics (LAMB), requires one (1) Brand Name Spectra-Physics (Newport Corporation / MKS Instruments) InSight® X3¿ Dual Ultrafast Laser System to integrate with an existing Thorlabs Veneto inverted multiphoton microscope for Fluorescence Lifetime Imaging Microscopy (FLIM) and Stimulated Raman Scattering (SRS) pump-probe experiments studying the effects of chemotherapeutic agents on cellular metabolism.
-Combined Synopsis11/20/2026

Additional Details

Solicitation Number

80NSSC26922479Q

Archive Date

Jan 28, 2026

Office Address

STENNIS SPACE CENTER, MS, 39529